Cigarette smoke enhances abdominal aortic aneurysm formation in angiotensin II-treated apolipoprotein E-deficient mice

Toxicology Letters

Volumn 199, Issue 3, 2010, Pages 403-409

  Stolle, Katrin ^a   Berges, An ^b   Lietz, Michael ^a   Lebrun, Stefan ^b   Wallerath, Thomas ^a  

^a Philip Morris Research Laboratories GmbH   (Germany)

^b PHILIP MORRIS PRODUCTS S A   (Switzerland)

Author keywords

Abdominal aortic aneurysm; Angiotensin II; Apo E knockout mice; Cigarette mainstream smoke; Metalloproteinases

Indexed keywords

ANGIOTENSIN II; APOLIPOPROTEIN E; CIGARETTE SMOKE; GELATINASE A; GELATINASE B; MACROPHAGE ELASTASE; NEUTROPHIL COLLAGENASE; STROMELYSIN;

ABDOMINAL AORTA ANEURYSM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROTIC PLAQUE; BLOOD PRESSURE; BODY WEIGHT; DISEASE SEVERITY; GENE EXPRESSION; HYPERLIPIDEMIA; HYPERTENSION; INCIDENCE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS;

ANGIOTENSIN II; ANIMALS; AORTIC ANEURYSM, ABDOMINAL; APOLIPOPROTEINS E; BLOOD PRESSURE; BODY WEIGHT; DISEASE MODELS, ANIMAL; MALE; MATRIX METALLOPROTEINASES; MICE; SMOKE; TISSUE INHIBITOR OF METALLOPROTEINASES; TOBACCO;

MUS;

EID: 78650517068     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2010.10.005     Document Type: Article

References (40)

1. Abdul-Hussien H., Soekhoe R.G., Weber E., von der Thusen J.H., Kleemann R., Mulder A., van Bockel J.H., Hanemaaijer R., Lindeman J.H. Collagen degradation in the abdominal aneurysm: a conspiracy of matrix metalloproteinase and cysteine collagenases. Am. J. Pathol. 2007, 170:809-817.
2. Abe N., Osanai T., Fujiwara T., Kameda K., Matsunaga T., Okumura K. C-reactive protein-induced upregulation of extracellular matrix metalloproteinase inducer in macrophages: inhibitory effect of fluvastatin. Life Sci. 2006, 78:1021-1028.
3. Applied Biosystems Relative quantitation of gene expression: ABI PRISM 7700 Sequence Detection System. User Bulletin #2: Rev. B 2001, Applied Biosystems, Weiterstadt, Germany.
4. Bender R., Lange S. Multiple test procedures other than Bonferroni's deserve wider use. BMJ 1999, 318:600-601.
5. Bergoeing M.P., Arif B., Hackmann A.E., Ennis T.L., Thompson R.W., Curci J.A. Cigarette smoking increases aortic dilatation without affecting matrix metalloproteinase-9 and -12 expression in a modified mouse model of aneurysm formation. J. Vasc. Surg. 2007, 45(6):1217-1227.
6. Brasier A.R., Recinos A., Eledrisi M.S. Vascular inflammation and the renin-angiotensin system. Arterioscler. Thromb. Vasc. Biol. 2002, 22:1257-1266.
7. Breslow J.L. Mouse models of atherosclerosis. Science 1996, 272:685-688.
8. Buckley C., Wyble C.W., Borhani M., Ennis T.L., Kobayashi D.K., Curci J.A., Shapiro S.D., Thompson R.W. Accelerated enlargement of experimental abdominal aortic aneurysms in a mouse model of chronic cigarette smoke exposure. J. Am. Coll. Surg. 2004, 199(6):896-903.
9. C.o.L.S.Institute of Laboratory Animal Research National Research Council Guide for the Care and Use of Laboratory Animals 1996, National Academy Press, Washington, DC.
10. Cassis L.A., Gupte M., Thayer S., Zhang X., Charnigo R., Howatt D.A., Rateri D.L., Daugherty A. ANG II infusion promotes abdominal aortic aneurysms independent of increased blood pressure in hypercholesterolemic mice. Am. J. Physiol. Heart Circ. Physiol. 2009, 296:H1660-H1665.
11. Daugherty A., Cassis L.A. Angiotensin II-mediated development of vascular diseases. Trends Cardiovasc. Med. 2004, 14:117-120.
12. Daugherty A., Cassis L.A. Mouse models of abdominal aortic aneurysms. Arterioscler. Thromb. Vasc. Biol. 2004, 24:429-434.
13. Daugherty A., Manning M.W., Cassis L.A. Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J. Clin. Invest. 2000, 105:1605-1612.
14. Doronzo G., Russo I., Mattiello L., Trovati M., Anfossi G. C-reactive protein increases matrix metalloproteinase-2 expression and activity in cultured human vascular smooth muscle cells. J. Lab. Clin. Med. 2005, 146:287-298.
15. Freestone T., Turner R.J., Coady A., Higman D.J., Greenhalgh R.M., Powell J.T. Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm. Arterioscler. Thromb. Vasc. Biol. 1995, 15:1145-1151.
16. Goodall S., Crowther M., Hemingway D.M., Bell P.R., Thompson M.M. Ubiquitous elevation of matrix metalloproteinase-2 expression in the vasculature of patients with abdominal aneurysms. Circulation 2001, 104:304-309.
17. International Organization for Standardization: International Standard ISO 3308 Routine Analytical Cigarette-Smoking Machine - Definitions and Standard Conditions 2000, 4th ed.
18. Janssens S., Lijnen H.R. What has been learned about the cardiovascular effects of matrix metalloproteinases from mouse models?. Cardiovasc. Res. 2006, 69:585-594.
19. Kim S., Iwao H. Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases. Pharmacol. Rev. 2000, 52:11-34.
20. Kon V., Jabs K. Angiotensin in atherosclerosis. Curr. Opin. Nephrol. Hypertens. 2004, 13:291-297.
21. Lloyd-Jones D., Adams R.J., Brown T.M., Carnethon M., Dai S., De Simone G., Ferguson T.B., Ford E., Furie K., Gillespie C., Go A., Greenlund K., Haase N., Hailpern S., Ho P.M., Howard V., Kissela B., Kittner S., Lackland D., Lisabeth L., Marelli A., McDermott M.M., Meigs J., Mozaffarian D., Mussolino M., Nichol G., Roger V.L., Rosamond W., Sacco R., Sorlie P., Stafford R., Thom T., Wasserthiel-Smoller S., Wong N.D., Wylie-Rosett J. Executive summary: heart disease and stroke statistics - 2010 update: a report from the American Heart Association. Circulation 2010, 121:948-954.
22. Matetzky S., Tani S., Kangavari S., Dimayuga P., Yano J., Xu H., Chyu K.Y., Fishbein M.C., Shah P.K., Cercek B. Smoking increases tissue factor expression in atherosclerotic plaques: implications for plaque thrombogenicity. Circulation 2000, 102:602-604.
23. Montecucco F., Pende A., Mach F. The renin-angiotensin system modulates inflammatory processes in atherosclerosis: evidence from basic research and clinical studies. Mediators Inflamm. 2009, 2009:752406.
24. Palazzuoli A., Gallotta M., Guerrieri G., Quatrini I., Franci B., Campagna M.S., Neri E., Benvenuti A., Sassi C., Nuti R. Prevalence of risk factors, coronary and systemic atherosclerosis in abdominal aortic aneurysm: comparison with high cardiovascular risk population. Vasc. Health Risk Manag. 2008, 4:877-883.
25. Prisant L.M., Mondy J.S. Abdominal aortic aneurysm. J. Clin. Hypertens. (Greenwich) 2004, 6:85-89.
26. Sakamoto H., Aikawa M., Hill C.C., Weiss D., Taylor W.R., Libby P., Lee R.T. Biomechanical strain induces class a scavenger receptor expression in human monocyte/macrophages and THP-1 cells: a potential mechanism of increased atherosclerosis in hypertension. Circulation 2001, 104:109-114.
27. Schroeter M.R., Sawalich M., Humboldt T., Leifheit M., Meurrens K., Berges A., Xu H., Lebrun S., Wallerath T., Konstantinides S., Schleef R., Schaefer K. Cigarette smoke exposure promotes arterial thrombosis and vessel remodeling after vascular injury in apolipoprotein E-deficient mice. J. Vasc. Res. 2008, 45:480-492.
28. Takagi H., Umemoto T. Smoking promotes pathogenesis of aortic aneurysm through the 5-lipoxygenase pathway. Med. Hypotheses 2005, 64:1117-1119.
29. Tham D.M., Martin-McNulty B., Wang Y.X., Da Cunha V., Wilson D.W., Athanassious C.N., Powers A.F., Sullivan M.E., Rutledge J.C. Angiotensin II injures the arterial wall causing increased aortic stiffening in apolipoprotein E-deficient mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2002, 283:R1442-1449.
30. The 2004 United States Surgeon General's Report The Health Consequences of Smoking. NSW Public Bull. 2004, 15(5-6):107.
31. Thompson R.W., Holmes D.R., Mertens R.A., Liao S., Botney M.D., Mecham R.P., Welgus H.G., Parks W.C. Production and localization of 92-kilodalton gelatinase in abdominal aortic aneurysms. An elastolytic metalloproteinase expressed by aneurysm-infiltrating macrophages. J. Clin. Invest. 1995, 96:318-326.
32. University of Kentucky Kentucky Tobacco Research and Development Center: The Reference Cigarette 2003, The University of Kentucky Printing Services, Lexington.
33. -/- model: 12-month exposure to cigarette mainstream smoke combined with high-cholesterol/fat diet. Atherosclerosis 2009, 205:135-143.
34. Weiss D., Kools J.J., Taylor W.R. Angiotensin II-induced hypertension accelerates the development of atherosclerosis in ApoE-deficient mice. Circulation 2001, 103:448-454.
35. Wilson W.R., Anderton M., Schwalbe E.C., Jones J.L., Furness P.N., Bell P.R., Thompson M.M. Matrix metalloproteinase-8 and -9 are increased at the site of abdominal aortic aneurysm rupture. Circulation 2006, 113:438-445.
36. World Health Organisation (WHO) Fact Sheet N 317- Cardiovascular Diseases (CVDs) 2009, http://www.who.int/mediacentre/factsheets/fs317/en/print.html (updated September 2009).
37. Wright J.L., Tai H., Wang R., Wang X., Churg A. Cigarette smoke upregulates pulmonary vascular matrix metalloproteinases via TNF-signaling. Am. J. Physiol. Lung Cell Mol. Physiol. 2007, 292:L125-L133.
38. Xiong W., Knispel R., Mactaggart J., Baxter B.T. Effects of tissue inhibitor of metalloproteinase 2 deficiency on aneurysm formation. J. Vasc. Surg. 2006, 44:1061-1066.
39. Zhang Y., Ramos K.S. The development of abdominal aortic aneurysms in mice is enhanced by benzo(a)pyrene. Vasc. Health Risk Manag. 2008, 4(5):1095-1102.
40. Zhou Y., Chen R., Catanzaro S.E., Hu L., Dansky H.M., Catanzaro D.F. Differential effects of angiotensin II on atherogenesis at the aortic sinus and descending aorta of apolipoprotein-E-deficient mice. Am. J. Hypertens. 2005, 18:486-492.